Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders
Copy number variants have emerged as an important genomic cause of common, complex neurodevelopmental disorders. These usually change copy number of multiple genes, but deletions at 2p16.3, which have been associated with autism, schizophrenia and mental retardation, affect only the neurexin 1 gene,...
Saved in:
Published in | PloS one Vol. 8; no. 6; p. e67114 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
28.06.2013
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Copy number variants have emerged as an important genomic cause of common, complex neurodevelopmental disorders. These usually change copy number of multiple genes, but deletions at 2p16.3, which have been associated with autism, schizophrenia and mental retardation, affect only the neurexin 1 gene, usually the alpha isoform. Previous analyses of neurexin 1α (Nrxn1α) knockout (KO) mouse as a model of these disorders have revealed impairments in synaptic transmission but failed to reveal defects in social behaviour, one of the core symptoms of autism.
We performed a detailed investigation of the behavioural effects of Nrxn1α deletion in mice bred onto a pure genetic background (C57BL/6J) to gain a better understanding of its role in neurodevelopmental disorders. Wildtype, heterozygote and homozygote Nrxn1α KO male and female mice were tested in a battery of behavioural tests (n = 9-16 per genotype, per sex).
In homozygous Nrxn1α KO mice, we observed altered social approach, reduced social investigation, and reduced locomotor activity in novel environments. In addition, male Nrxn1α KO mice demonstrated an increase in aggressive behaviours.
These are the first experimental data that associate a deletion of Nrxn1α with alterations of social behaviour in mice. Since this represents one of the core symptom domains affected in autism spectrum disorders and schizophrenia in humans, our findings suggest that deletions within NRXN1 found in patients may be responsible for the impairments seen in social behaviours, and that the Nrxn1α KO mice are a useful model of human neurodevelopmental disorder. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: Regarding the financial disclosure, the authors confirm that David A. Collier is a full time employee of Eli Lilly and Company Ltd. (since April 2012), and a visiting professor at the Institute of Psychiatry. David A. Collier is also a stockholder of Eli Lilly and Company. Eli Lilly and company provided an unrestricted educational grant to contribute to the breeding costs of the NRXN1 mice used in the present study. The present study does not relate to any patents, intellectual property, products in development or marketed products by Eli Lilly and Company. Cathy Fernandes has received an honorarium from Eli Lilly and Company Ltd. as a seminar speaker. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: HG CF DAC. Performed the experiments: HG CF. Analyzed the data: HG CF. Contributed reagents/materials/analysis tools: MM DAC. Wrote the paper: HG CF MM DAC. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0067114 |